Search research articles
Contact Us
Filters
Showing results (141-150 of 187) with videos related to
Page
of 19
Sort By:
American Journal of Clinical Pathology
|
February 1, 1984
Interferon-related leukocyte inclusions in acquired immune deficiency syndrome: localization in T cells
P M Grimley, Y H Kang, W Frederick, et al.
The Journal of Infectious Diseases
|
July 1, 1985
Viral infections and cell-mediated immunity in immunodeficient homosexual men with Kaposi's sarcoma treated with human lymphoblastoid interferon
W R Frederick, J S Epstein, E P Gelmann, et al.
American Journal of Hematology
|
February 28, 2012
The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients
Michael J Kelly-Sell, Youn H Kim, Suzanne Straus, et al.
The Journal of Infectious Diseases
|
October 1, 1985
Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome
J S Epstein, W R Frederick, A H Rook, et al.
Leukemia & Lymphoma
|
March 21, 2015
Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma
Ellen J Kim, Youn H Kim, Alain H Rook, et al.
The Journal of Clinical Investigation
|
July 1, 1983
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome
A H Rook, H Masur, H C Lane, et al.
Journal of Clinical Immunology
|
July 1, 1989
A phase I trial of recombinant human interferon-gamma in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS)
H C Lane, R T Davey, S A Sherwin, et al.
American Journal of Hematology
|
June 5, 2007
Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine
Stephen K Richardson, Sarah B Newton, Tami L Bach, et al.
The Journal of Investigative Dermatology
|
June 25, 2013
CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in Sézary syndrome patients
Maria Wysocka, Andrew V Kossenkov, Bernice M Benoit, et al.
Bone Marrow Transplantation
|
October 25, 2011
Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas
V R Paralkar, S D Nasta, K Morrissey, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 187) with videos related to
Sort By:
Page
of 19
American Journal of Clinical Pathology
|
February 1, 1984
Interferon-related leukocyte inclusions in acquired immune deficiency syndrome: localization in T cells
P M Grimley, Y H Kang, W Frederick, et al.
The Journal of Infectious Diseases
|
July 1, 1985
Viral infections and cell-mediated immunity in immunodeficient homosexual men with Kaposi's sarcoma treated with human lymphoblastoid interferon
W R Frederick, J S Epstein, E P Gelmann, et al.
American Journal of Hematology
|
February 28, 2012
The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients
Michael J Kelly-Sell, Youn H Kim, Suzanne Straus, et al.
The Journal of Infectious Diseases
|
October 1, 1985
Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome
J S Epstein, W R Frederick, A H Rook, et al.
Leukemia & Lymphoma
|
March 21, 2015
Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma
Ellen J Kim, Youn H Kim, Alain H Rook, et al.
The Journal of Clinical Investigation
|
July 1, 1983
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome
A H Rook, H Masur, H C Lane, et al.
Journal of Clinical Immunology
|
July 1, 1989
A phase I trial of recombinant human interferon-gamma in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS)
H C Lane, R T Davey, S A Sherwin, et al.
American Journal of Hematology
|
June 5, 2007
Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine
Stephen K Richardson, Sarah B Newton, Tami L Bach, et al.
The Journal of Investigative Dermatology
|
June 25, 2013
CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in Sézary syndrome patients
Maria Wysocka, Andrew V Kossenkov, Bernice M Benoit, et al.
Bone Marrow Transplantation
|
October 25, 2011
Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas
V R Paralkar, S D Nasta, K Morrissey, et al.
Page
of 19